Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2024
Primary Cilia as a Tumor Marker in Pituitary Neuroendocrine Tumors.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Martínez-Hernández Rebeca, Serrano-Somavilla Ana, Fernández-Contreras Raul, Sanchez-Guerrero Cristina, Sánchez de la Blanca Nuria, Sacristán-Gómez Pablo, Sebastian-Valles Fernando, Sampedro-Núñez Miguel, Fraga Javier, Calatayud María, Vicente Almudena, García-de-Casasola Gonzalo, Sanz-García Ancor, Araujo-Castro Marta, Ruz-Caracuel Ignacio, Puig-Domingo Manel, Marazuela Mónica
Аннотация
Pituitary neuroendocrine tumors (PitNETs) account for approximately 15% of all intracranial neoplasms. Although they usually appear to be benign, some tumors display worse behavior, displaying rapid growth, invasion, refractoriness to treatment, and recurrence. Increasing evidence supports the role of primary cilia (PC) in regulating cancer development. Here, we showed that PC are significantly increased in PitNETs and are associated with increased tumor invasion and recurrence. Serial electron micrographs of PITNETs demonstrated different ciliation phenotypes (dot-like versus normal-like cilia) that represented PC at different stages of ciliogenesis. Molecular findings demonstrated that 123 ciliary-associated genes (eg, doublecortin domain containing protein 2, Sintaxin-3, and centriolar coiled-coil protein 110) were dysregulated in PitNETs, representing the upregulation of markers at different stages of intracellular ciliogenesis. Our results demonstrate, for the first time, that ciliogenesis is increased in PitNETs, suggesting that this process might be used as a potential target for therapy in the future.